{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:17:31Z","timestamp":1785799051517,"version":"3.56.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,19]]},"abstract":"<jats:p>Immune cells and inflammatory cytokines collectively contribute to the pathogenesis of rosacea. However, the causality between immune cells, inflammatory cytokines and rosacea remains unclear. This study employed Mendelian randomization analysis to investigate the causality among 731 immune cells, 91 inflammatory cytokines, and rosacea. The inverse variance weighted, Mendelian randomization Egger, simple mode, weighted median, and weighted mode analyses were implemented to investigate causality. Sensitivity analyses were conducted to evaluate reliability of findings. Our research results indicated that 3 immune cells can increase risk of rosacea, 4 immune cells can decrease risk of rosacea. Among them, transitional (TR) B cell %lymphocyte (odds ratio [OR]\u2005=\u20051.170, 95% confidence interval [CI]\u2005=\u20051.001\u20131.368), CD25 on IgD\u2212 CD24\u2212 B cell (OR\u2005=\u20051.151, 95% CI\u2005=\u20051.013\u20131.307), and HLA DR on CD14\u2212 CD16+ monocyte (OR\u2005=\u20051.136, 95% CI\u2005=\u20051.007\u20131.281) increased risk of rosacea. Central memory CD4\u2212 CD8\u2212 T cell absolute count (OR\u2005=\u20050.952, 95% CI\u2005=\u20050.889\u20131.019), CCR7 on naive CD4+ T cell (OR\u2005=\u20050.928, 95% CI\u2005=\u20050.866\u20130.995), CD14+ CD16\u2212 monocyte absolute count (OR\u2005=\u20050.915, 95% CI\u2005=\u20050.857\u20130.977), and CD62L\u2212 myeloid dendritic cell (mDC; OR\u2005=\u20050.928, 95% CI\u2005=\u20050.862\u20130.999) decreased risk of rosacea. Meanwhile, the findings revealed that C-X-C motif chemokine 11 (CXCL11) levels (OR\u2005=\u20051.265, 95% CI\u2005=\u20050.985\u20131.625) and T-cell surface glycoprotein CD6 isoform levels (OR\u2005=\u20051.372, 95% CI\u2005=\u20051.069\u20131.761) increased risk of rosacea, while monocyte chemoattractant protein-1 levels (OR\u2005=\u20050.772, 95% CI\u2005=\u20050.621\u20130.960) and programmed cell death 1 ligand 1 levels (OR\u2005=\u20050.739, 95% CI\u2005=\u20050.557\u20130.981) decreased risk of rosacea. This study establishes a theoretical framework for comprehensively investigating the relationships between immune cells, inflammatory cytokines, and rosacea. It also offers valuable references for identifying novel therapeutic targets for rosacea.<\/jats:p>","DOI":"10.1097\/md.0000000000046719","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T04:01:17Z","timestamp":1766203277000},"page":"e46719","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the role of immune cell and inflammatory cytokines in the development of rosacea"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4463-5714","authenticated-orcid":false,"given":"Yang","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Dermatology, Beijing Anzhen Nanchong Hospital of Capital Medical University, Nanchong Central Hospital, Nanchong, Sichuan Province, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhua","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Beijing Anzhen Nanchong Hospital of Capital Medical University, Nanchong Central Hospital, Nanchong, Sichuan Province, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260522","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1056\/NEJMcp1506630","article-title":"Rosacea.","volume":"377","author":"van Zuuren","year":"2017","journal-title":"N Engl J Med"},{"key":"R2-20260522","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s40257-021-00595-7","article-title":"Rosacea: new concepts in classification and treatment.","volume":"22","author":"van Zuuren","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"R3-20260522","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2020.0417","article-title":"Rosacea.","volume":"82","author":"Searle","year":"2021","journal-title":"Br J Hosp Med (Lond)"},{"key":"R4-20260522","first-page":"70","article-title":"Update on rosacea classification and its controversies.","volume":"104","author":"Wang","year":"2019","journal-title":"Cutis"},{"key":"R5-20260522","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jad.2021.12.008","article-title":"Association of rosacea with depression and anxiety: a systematic review and meta-analysis.","volume":"299","author":"Chang","year":"2022","journal-title":"J Affect Disord"},{"key":"R6-20260522","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/13548506.2017.1361540","article-title":"The dermatology life quality index (DLQI) and the hospital anxiety and depression (HADS) in Chinese rosacea patients.","volume":"23","author":"Wu","year":"2018","journal-title":"Psychol Health Med"},{"key":"R7-20260522","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jaad.2017.07.055","article-title":"Evidence-based update on rosacea comorbidities and their common physiologic pathways.","volume":"78","author":"Holmes","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R8-20260522","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.clindermatol.2019.07.032","article-title":"Is rosacea a systemic disease?","volume":"37","author":"Wollina","year":"2019","journal-title":"Clin Dermatol"},{"key":"R9-20260522","first-page":"282","article-title":"Incidence and prevalence of rosacea: a systematic review and meta-analysis.","volume":"179","author":"Gether","year":"2018","journal-title":"Br J Dermatol"},{"key":"R10-20260522","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.det.2017.11.001","article-title":"Rosacea pathogenesis.","volume":"36","author":"Ahn","year":"2018","journal-title":"Dermatol Clin"},{"key":"R11-20260522","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/12034754241229365","article-title":"Rosacea: pathogenesis and therapeutic correlates.","volume":"28","author":"Geng","year":"2024","journal-title":"J Cutan Med Surg"},{"key":"R12-20260522","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1038\/jid.2015.141","article-title":"Molecular and morphological characterization of inflammatory infiltrate in rosacea reveals activation of Th1\/Th17 pathways.","volume":"135","author":"Buhl","year":"2015","journal-title":"J Invest Dermatol"},{"key":"R13-20260522","doi-asserted-by":"crossref","first-page":"674871","DOI":"10.3389\/fimmu.2021.674871","article-title":"Keratinocyte-immune cell crosstalk in a STAT1-mediated pathway: novel insights into rosacea pathogenesis.","volume":"12","author":"Deng","year":"2021","journal-title":"Front Immunol"},{"key":"R14-20260522","doi-asserted-by":"crossref","first-page":"F1000 Faculty Rev","DOI":"10.12688\/f1000research.16537.1","article-title":"Recent advances in understanding and managing rosacea.","volume":"7","author":"Buddenkotte","year":"2018","journal-title":"F1000Res"},{"key":"R15-20260522","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jdermsci.2018.12.004","article-title":"Botulinum toxin blocks mast cells and prevents rosacea like inflammation.","volume":"93","author":"Choi","year":"2019","journal-title":"J Dermatol Sci"},{"key":"R16-20260522","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fncel.2019.00422","article-title":"Mast cells and sensory nerves contribute to neurogenic inflammation and pruritus in chronic skin inflammation.","volume":"13","author":"Siiskonen","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"R17-20260522","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fmed.2019.00324","article-title":"The theranostics role of mast cells in the pathophysiology of rosacea.","volume":"6","author":"Wang","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"R18-20260522","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/1346-8138.16329","article-title":"Increased serum levels of CCL3, CXCL8, CXCL9, and CXCL10 in rosacea patients and their correlation with disease severity.","volume":"49","author":"Liu","year":"2022","journal-title":"J Dermatol"},{"key":"R19-20260522","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jid.2021.12.009","article-title":"N2-polarized neutrophils reduce inflammation in rosacea by regulating vascular factors and proliferation of CD4(+) T cells.","volume":"142","author":"Zhao","year":"2022","journal-title":"J Invest Dermatol"},{"key":"R20-20260522","doi-asserted-by":"crossref","first-page":"e10548","DOI":"10.7717\/peerj.10548","article-title":"Cinnamtannin B1 attenuates rosacea-like signs via inhibition of pro-inflammatory cytokine production and down-regulation of the MAPK pathway.","volume":"8","author":"Kan","year":"2020","journal-title":"PeerJ"},{"key":"R21-20260522","doi-asserted-by":"crossref","first-page":"156887","DOI":"10.1016\/j.cyto.2025.156887","article-title":"Circulating inflammatory cytokines and risk of aortic stenosis: a Mendelian randomization analysis.","volume":"189","author":"Qiu","year":"2025","journal-title":"Cytokine"},{"key":"R22-20260522","doi-asserted-by":"crossref","first-page":"a040501","DOI":"10.1101\/cshperspect.a040501","article-title":"Mendelian randomization: concepts and scope.","volume":"12","author":"Richmond","year":"2022","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R23-20260522","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/ije\/dyac149","article-title":"Tools for assessing quality and risk of bias in Mendelian randomization studies: a systematic review.","volume":"52","author":"Spiga","year":"2023","journal-title":"Int J Epidemiol"},{"key":"R24-20260522","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","article-title":"Complex genetic signatures in immune cells underlie autoimmunity and inform therapy.","volume":"52","author":"Orr\u00f9","year":"2020","journal-title":"Nat Genet"},{"key":"R25-20260522","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","article-title":"Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.","volume":"24","author":"Zhao","year":"2023","journal-title":"Nat Immunol"},{"key":"R26-20260522","doi-asserted-by":"crossref","first-page":"19797","DOI":"10.1038\/s41598-025-05553-5","article-title":"Causal association between oral microbiota and oral cancer: a mendelian randomization study.","volume":"15","author":"Wu","year":"2025","journal-title":"Sci Rep"},{"key":"R27-20260522","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/gepi.21998","article-title":"Bias due to participant overlap in two-sample Mendelian randomization.","volume":"40","author":"Burgess","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R28-20260522","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1177\/0962280215597579","article-title":"A review of instrumental variable estimators for Mendelian randomization.","volume":"26","author":"Burgess","year":"2017","journal-title":"Stat Methods Med Res"},{"key":"R29-20260522","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/s41588-018-0164-2","article-title":"Publisher correction: detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R30-20260522","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/jdv.12121","article-title":"Rosacea under the microscope: characteristic histological findings.","volume":"27","author":"Cribier","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R31-20260522","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-3083.2006.01832.x","article-title":"B-cell CD25 expression in murine primary and secondary lymphoid tissue.","volume":"64","author":"Amu","year":"2006","journal-title":"Scand J Immunol"},{"key":"R32-20260522","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1749-6632.1994.tb17258.x","article-title":"Cell differentiation and proliferation in the gastrointestinal tract with respect to the local immune system.","volume":"733","author":"Zeitz","year":"1994","journal-title":"Ann N Y Acad Sci"},{"key":"R33-20260522","doi-asserted-by":"crossref","first-page":"15469","DOI":"10.1038\/s41598-022-19847-5","article-title":"Distinct gene expression patterns for CD14++ and CD16++ monocytes in preeclampsia.","volume":"12","author":"Vishnyakova","year":"2022","journal-title":"Sci Rep"},{"key":"R34-20260522","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1189\/jlb.0806510","article-title":"The CD14+ CD16+ blood monocytes: their role in infection and inflammation.","volume":"81","author":"Ziegler-Heitbrock","year":"2007","journal-title":"J Leukoc Biol"},{"key":"R35-20260522","doi-asserted-by":"crossref","first-page":"9068","DOI":"10.1038\/s41598-023-36247-5","article-title":"Evaluation of inflammatory status in blood in patients with rosacea.","volume":"13","author":"Karaosmanoglu","year":"2023","journal-title":"Sci Rep"},{"key":"R36-20260522","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2147\/CCID.S336194","article-title":"Increased frequency of circulating classical monocytes in patients with rosacea.","volume":"14","author":"Gao","year":"2021","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"R37-20260522","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/iid3.416","article-title":"Current research status of HLA in immune-related diseases.","volume":"9","author":"Liu","year":"2021","journal-title":"Immun Inflamm Dis"},{"key":"R38-20260522","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3389\/fimmu.2013.00260","article-title":"HLA-DO and its role in MHC class II antigen presentation.","volume":"4","author":"Poluektov","year":"2013","journal-title":"Front Immunol"},{"key":"R39-20260522","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/jidsymp.2011.9","article-title":"The cytokine and chemokine network.","volume":"15","author":"Gerber","year":"2011","journal-title":"J Investig Dermatol Symp Proc"},{"key":"R40-20260522","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2340\/00015555-1775","article-title":"Calcipotriol increases hCAP18 mRNA expression but inhibits extracellular LL37 peptide production in IL-17\/IL-22-stimulated normal human epidermal keratinocytes.","volume":"94","author":"Sakabe","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"R41-20260522","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaad.2014.01.892","article-title":"Comparative analysis of rosacea and cutaneous lupus erythematosus: histopathologic features, T-cell subsets, and plasmacytoid dendritic cells.","volume":"71","author":"Brown","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R42-20260522","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.imbio.2014.12.010","article-title":"Myeloid dendritic cells: development, functions, and role in atherosclerotic inflammation.","volume":"220","author":"Chistiakov","year":"2015","journal-title":"Immunobiology"},{"key":"R43-20260522","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1126\/science.1178331","article-title":"Development of monocytes, macrophages, and dendritic cells.","volume":"327","author":"Geissmann","year":"2010","journal-title":"Science"},{"key":"R44-20260522","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.3390\/ijms17091562","article-title":"Rosacea: molecular mechanisms and management of a chronic cutaneous inflammatory condition.","volume":"17","author":"Woo","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R45-20260522","doi-asserted-by":"crossref","first-page":"155444","DOI":"10.1016\/j.cyto.2021.155444","article-title":"Identification of novel candidate genes in rosacea by bioinformatic methods.","volume":"141","author":"Sun","year":"2021","journal-title":"Cytokine"},{"key":"R46-20260522","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1111\/febs.15236","article-title":"Host engulfment pathway controls inflammation in inflammatory bowel disease.","volume":"287","author":"Sayed","year":"2020","journal-title":"FEBS J"},{"key":"R47-20260522","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1126\/science.aaf1292","article-title":"T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition.","volume":"355","author":"Hui","year":"2017","journal-title":"Science"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046719","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:00:55Z","timestamp":1779433255000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":47,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046719","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"2025-08-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}